Diabetic Retinopathy Market Size PowerPoint PPT Presentations

Global proliferative diabetic retinopathy (pdr) market size is expected at 3.62 Bn by 2028 at a growth rate of 10.6% and growth analysis by The Business Research Company.

Market Size - $6.5 Billion in 2015, Market Growth - CAGR of 6.9%, Market Trends –Availability of better drug molecules for the treatment

Diabetic Retinopathy Market Size By Type, By Management, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023

Diabetic Retinopathy Market focuses on the global Diabetic Retinopathy status, future forecast, growth opportunity, key market and key players

The global diabetic socks market size was USD 344.80 Million in 2021 and is expected to register a revenue CAGR of 4.8% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of diabetics and related complications such as Diabetic Food Ulcer (DFC) and diabetic neuropathy, growing consumer demand for better & improved accessibility and benefits offered by diabetic socks to patients over regular socks, and introduction of innovative smart sock technology are factors driving market revenue growth.

Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease. Read more details at: http://www.bigmarketresearch.com/global-diabetic-retinopathy-2015-2019-market

This report offers an analysis of the market based on product (reusable ophthalmic knives and single-use ophthalmic knives). The ophthalmic knives market research report further presents an in-depth insight on the growth prospects of the market across Asia, Europe, North America, and ROW. The report analyzes the market’s competitive landscape and offers information on several companies including Bausch Health, Diamatrix Ltd., HAI Laboratories, Inc., MANI, INC., Novartis AG, and Sidapharm.

This report offers an analysis of the market based on product (reusable ophthalmic knives and single-use ophthalmic knives). The ophthalmic knives market research report further presents an in-depth insight on the growth prospects of the market across Asia, Europe, North America, and ROW. The report analyzes the market’s competitive landscape and offers information on several companies including Bausch Health, Diamatrix Ltd., HAI Laboratories, Inc., MANI, INC., Novartis AG, and Sidapharm.

Get more information @ http://bit.ly/2kq4uSV Some of the key players in the diabetic retinopathy market include Bayer, Valeant Pharmaceutical, Novartis, F. Hoffmann-La Roche, Alimera Science, Abbott Laboratories, Pfizer, Regeneron Pharmaceutical, and Ampio Pharmaceuticals. Other notable players include Actavis, Boehringer Ingelheim, Kowa group, BCN peptides, ThromboGenics, Bausch & Lomb, iCo Therapeutics, Quark Pharmaceuticals and Vitreoretinal Technologies among others.

The research team projects that the Diabetic Retinopathy Treatment market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.

Get more information @ http://bit.ly/2kq4uSV North America is predicted to contribute maximum revenue share in access of $4 billion by end of forecast timeframe. Growing access to anti-VEGF items like lucentis, eyelea and avastin along with growing consciousness for early diagnosis to avoid further blindness related with diabetes are the factors predicted to drive the industry demand in the region.

New Market Research Reports Title Optical Coherence Tomography Market " Has Been Added to Adroit Market Research into reports database.

Global eylea market size is expected to reach $10.16 Bn by 2028 at a rate of 5.5%, segmented as by product, prefilled syringe package, vial package

Stay up-to-date with latest Insights of Ophthalmic Drugs Market research offered by Allied Market Research. Check how key trends and emerging drivers are shaping this industry growth. Get More Info@ https://www.alliedmarketresearch.com/ophthalmic-drugs-market

Market Size – USD 7.39 billion in 2018, Market Growth – CAGR of 7.3%, Market Trends – Product Launches and Research for Advanced Tech Developments

The global retinal imaging devices market is growing at a CAGR of 5.93% and is expected to reach $9322.89 million, during the forecast period of 2023-2032.

Global Widefield Imaging Systems Market will exhibit a CAGR of around 7.35% for the forecast period of 2022-2028. Widefield imaging systems are used in diagnosing and detecting uveitis, diabetic retinopathy, retinal vascular tumours among others. Widefield imaging systems offer excellent postoperative documentation of retinal surgery. Widefield imaging systems is an imaging technology that relies on illumination with the resulting image being viewed and observed by an observer through the camera. The widefield imaging systems are rapidly being adopted by hospitals, clinics, and ambulatory surgery centres. Get Full Access of Report @ https://www.databridgemarketresearch.com/reports/global-widefield-imaging-systems-market

Overview of Vitrectomy Devices Market Report Helps In Providing Scope and Definitions, Key Findings, Growth Drivers, and Various Dynamics.

The global ophthalmic equipment market size was USD 60.49 Billion in 2021 and is expected to register a revenue CAGR of 5.0% during the forecast period, according to latest analysis by Emergen Research. Rising prevalence of glaucoma, cataracts, and other ocular conditions, increasing need for Research & Development (R&D) due to prevalence of eye-related diseases, need for improved patient outcomes, and use of cutting-edge technologies are major factors driving market revenue growth.

In 2017, sales of neuromodulation devices remained on the upside and a similar trend is likely to follow in 2018. Neuromodulation has gained significant traction over the past couple of years, which has reflected favourably on the Global Neuromodulation Devices Market.

In 2017, sales of neuromodulation devices remained on the upside and a similar trend is likely to follow in 2018. Neuromodulation has gained significant traction over the past couple of years, which has reflected favourably on the Global Neuromodulation Devices Market.

Grape Seed Extracts Industry is expected to register 7.5% CAGR between 2021 and 2027, supported by rising importance of grape seed extracts as a functional ingredient that aids in weight loss, cellulite reduction, and improvement of the immune system.The Grape Seed Extracts Market value is expected to cross USD 227 million by 2027, according to a new research report by Global Market Insights Inc. Increasing consumer inclination towards health & wellness coupled with favourable antioxidant, antifungal and anti-inflammatory properties of product will escalate the product demand.

Lutein Market Size, Industry Analysis Report, Regional Outlook, Application Development, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024

The major factors that drive the growth of the global ocular drug delivery technology market are the low bioavailability of drugs in conventional ocular therapies, increase in the incidence of glaucoma & macular degeneration, growing demand for targeted ocular drug delivery techniques, and increase in the number of approvals from government regulations for new ocular drug delivery techniques. Get sample copy of this report: https://goo.gl/S9nZMM

The global ophthalmic medical lasers market size is expected to grow from $1.04 billion in 2021 to $1.12 billion in 2022 at a compound annual growth rate (CAGR) of 7.6%.

The major competitors covered in the ophthalmic medical lasers market report are Alcon Laboratories Inc, Abbott Medical Optics Inc., Carl Zeiss Meditec AG. Read More @ http://bit.ly/3r49LPt

Global Dermatitis Market by The Business Research Company is segmented as Corticosteroids, Emollients/Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors https://bit.ly/3j2DKnH

Ophthalmology is basically the branch of medical science study of the eye and its various structure, function and treatment, cure and diagnosis of eye diseases and clinical conditions, such as cataract, diabetic retinopathy, age-related macular degeneration, glaucoma and astigmatism. The ophthalmology devices are medical equipment designed for surgery, diagnosis and vision correction.

An ophthalmic laser is a suitable apparatus for clinical indicative strategies and certain medical techniques. The company profiles include business overview of the company, financial highlights, products and recent developments related to Ophthalmic Lasers market. The report includes detailed competitive landscape of the global ophthalmology laser market such as, mergers, acquisitions, joint ventures, collaborations, new product launches and contracts.

The study segments the diabetic retinopathy industry in light of major classification such as product type, potential markets, application, and end-user.

Global Market Estimates is a market research and business consulting company who has proven track record in serving Fortune 500 companies.

Get more information about the market: https://www.imarcgroup.com/vision-care-market According to IMARC Group’s latest report, titled “Vision Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023”, the global vision care market reached a value of US$ 54 Billion in 2017. Request a sample report: https://www.imarcgroup.com/request?type=report&id=846&flag=B Browse more reports on Healthcare industry: http://www.imarcgroup.com/categories/healthcare-market-research-reports contact Us IMARC Group USA: +1-631-791-1145 Email: sales@imarcgroup.com Follow us on twitter: @imarcglobal

Get more information about the market : http://www.imarcgroup.com/vision-care-market Good vision plays an important role in conducting different activities such as reading, writing, watching TV, etc. According to IMARC Group’s latest report, titled “Vision Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, the global vision care market reached a value of US$ 54 Billion in 2016. Request a sample report : http://www.imarcgroup.com/request?type=report&id=846&flag=B Browse more reports on Healthcare industry: http://www.imarcgroup.com/categories/healthcare-market-research-reports Contact Us IMARC Group USA: +1-631-791-1145 Email: sales@imarcgroup.com Follow us on twitter: @imarcglobal

The growth of the injectable drug delivery technologies market is primarily triggered by favorable reimbursement policies on injectable drugs and devices, technological advancements, surge of biologics in pharmaceutical markets, rising incidences of cancer and diabetes in Europe, and improving patient compliance. See Full Report : http://bit.ly/1c4gocE

Global Market Estimates is a market research and business consulting company who has proven track record in serving Fortune 500 companies.

Global Market Estimates is a market research and business consulting company who has proven track record in serving Fortune 500 companies. Request for a sample copy of the Lutein Supplement Market report @: https://www.globalmarketestimates.com/lutein-supplement-market/

Global Market Estimates is a market research and business consulting company who has proven track record in serving Fortune 500 companies Request for a sample copy of the Lutein Vitamin Market report @: https://www.globalmarketestimates.com/lutein-vitamin-market/

Medical Wide field Imaging Systems Market, by Component (Instruments, Software), Modality (Standalone, Portable), End-User (Specialty Clinics, Hospitals, Ambulatory Surgical Centers) – Global Revenue, Trends, Growth, Share, Size, and Forecast To 2022

Patients suffering from these disorders are required to be delivered with the medications on a regular basis to stabilize the condition of the patients.

The study segments diabetic retinopathy industry in light of major classification such as product type, potential markets, application, and end-user.

The global ocular drug delivery market size valued at $67.7 billion in 2022, and is projected to reach $115.5 billion by 2032, growing at a CAGR of 5.5% from 2023 to 2032. The ocular drug delivery market growth is driven by advancement in ocular drug delivery technology, surge in ageing population, and rise in awareness about the various eye disorders. Aged population increases susceptibility to conditions such as age-related macular degeneration (AMD), cataracts, glaucoma, and diabetic retinopathy. Know More- https://www.alliedmarketresearch.com/ocular-drug-delivery-market

Ophthalmoscopes Market

The rising incidences of colorectal cancer, chronic pain, cardiovascular diseases and diabetic retinopathy and unwanted pregnancies globally are expected to drive the implantable drug delivery devices market.

The vascular endothelial growth factor (VEGF) inhibitor market size is expected to see strong growth in the next few years. It will grow to $13.98 billion in 2028 at a compound annual growth rate (CAGR) of 7.5%.

According to the latest research report by IMARC Group, The global eye health supplements market size is projected to exhibit a growth rate (CAGR) of 5.4% during 2024-2032. More Info:- https://www.imarcgroup.com/eye-health-supplements-market

The Business Research Company offers ocular implants market research report 2023 with industry size, share, segments and market growth

According to the latest research report by IMARC Group, The global ophthalmic devices market size reached US$ 27.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 38.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032. More Info:- https://www.imarcgroup.com/ophthalmic-devices-market

Global retinal disorder treatment market size is expected at $16.42 Bn by 2027, at a growth rate of 9.1% and growth analysis by The Business Research Company.

According to the latest research report by IMARC Group, The global vision care market size reached US$ 71.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 93.9 Billion by 2032, exhibiting a growth rate (CAGR) of 3% during 2024-2032. More Info:- https://www.imarcgroup.com/vision-care-market

Global eye health supplements market size is expected at $2.72 Bn by 2027 at a growth rate of 7.6% and share analysis by The Business Research Company.

Ophthalmic Lasers Market size in 2019 is estimated to be $968 million, growing at a CAGR of 5.3% during the forecast period 2020-2025.

Vitrectomy serves as major treatment option that has gained popularity since the past few years and also offers retina correction for the entire field of the interior of the eye, which includes the peripheral vision. Moreover, when it comes to defining Vitrectomy, it is a surgical procedure employed to eradicate vitreous gel from the eye. This process is done when there is an occurrence of retinal detachment with vitreous haemorrhage. In addition, this procedure is used for eradication of scar tissue and treatment for small holes or tear in the macula.

Eye Health Supplements Market size is estimated at $2.1 billion in 2020, projected to grow at a CAGR of 6.1% during the forecast period 2021-2026.

The entire market for Microvascular Complications of Diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic retinopathy segment of the market has recently seen rapid uptake of novel anti-VEGF therapies and is experiencing a strong growth. On the other hand, the diabetic neuropathy and nephropathy segments face the barrier in and increasing number of generic competitors. Optina (danazol) has been developed by Ampio Pharmaceuticals and is currently in Phase III trials for the treatment of diabetic retinopathy and DME. Effective non-surgical drug treatment of diabetic retinopathy is a high unmet need and Optina is the only drug in late-phase development addressing this need. Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=147162 .

According to Prevent Blindness statistics, the prevalence of diabetic retinopathy in the U.S. is estimated to be 5.3%. VEGF-A antagonist is largely prescribed for the diabetic retinopathy treatment and also for treatment of diabetic macular edema.

The ophthalmic devices refer to the type of devices that are utilized in the diagnosis and treatment of eyes associated diseases such as vision loss due to aging, glaucoma treatment, cataract surgeries, peripheral vitreoretinal disease, and refractive eye state, among others. The technological advancements across the globe acts as one of the major factors driving the growth of ophthalmic surgical instruments market. The increase in prevalence of eye disorders, such as glaucoma, cataract, and vitreoretinal disorders, and rise in preference for minimally invasive surgical options that provide permanent solutions to common ophthalmic conditions accelerate the market growth.